Healio

Xcopri provides long-term seizure control in patients with focal epilepsy

Please provide your email address to receive an email when new articles are posted on . Long-term use of Xcopri was safe and reduced seizures by more than 90% in adults with uncontrolled focal ...
Forbes

XCOPRI Reduces Number Of Partial-Onset Seizures In Adults, Earns FDA Approval

Last week, the FDA approved XCOPRI (cenobamate tablets) to treat partial-onset seizures in adults. This approval will help offer additional aid for the many individuals throughout the world who live ...
Monthly Prescribing Reference

Epilepsy Therapy Xcopri Designated Schedule V Controlled Substance

The DEA has designated Xcopri (cenobamate; SK Life Science) as a schedule V controlled substance, indicating a lower potential for abuse. The Drug Enforcement Administration (DEA) has designated ...
The Trentonian

Long-Term Safety and Tolerability of XCOPRI(R) (cenobamate tablets) CV Published in Epilepsia

PARAMUS, N.J., July 20, 2021 /PRNewswire/ — SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for ...
Monthly Prescribing Reference

Xcopri Now Available for Partial-Onset Seizures in Adults

SK Life Science has announced the availability of Xcopri (cenobamate) tablets for the treatment of partial-onset seizures in adults.  SK Life Science has announced the availability of Xcopri ...
FiercePharma

SK Life Science debuts Xcopri virtual effort for HCPs to empathize with seizure patients' experiences

SK Life Science is inviting healthcare providers to literally put themselves in the shoes of patients with seizures—well, in a virtual way. The company's immersive “Step into Their Shoes” experience, ...
MM&M

Xcopri is making a splash with rainstorm experience at AAN

The spring sun may or may not break through the Boston clouds during this weekend’s annual meeting of the American Academy of Neurology (AAN). Regardless, it will be raining inside the exhibit hall.
Healio

FDA approves XCOPRI for partial-onset seizures

Please provide your email address to receive an email when new articles are posted on . The FDA recently approved XCOPRI for adults with partial-onset seizures, its manufacturer announced. “The ...
WNCT

XCOPRI® (cenobamate tablets) CV Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a ...

PARAMUS, N.J., April 11, 2024 /PRNewswire/ -- SK Life Science, Inc., a U.S. pharmaceutical company developing treatments that will change the future of central nervous system (CNS) disorders and a ...
AOL

Is Xcopri covered by Medicare?

Xcopri (cenobamate) is a Schedule V antiseizure prescription tablet that treats partial onset seizures in adults. This seizure type affects a single brain area rather than causing widespread ...
Medical News Today

Is Xcopri covered by Medicare?

Private insurers manage these plans, so coverage depends on each plan’s formulary. However, if a plan excludes Xcopri, it typically covers a comparable alternative. The out-of-pocket cost of Xcopri ...